表紙
市場調査レポート

四肢麻痺:世界の治験レビュー

Quadriplegia / Tetraplegia Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 308253
出版日 ページ情報 英文 50 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
四肢麻痺:世界の治験レビュー Quadriplegia / Tetraplegia Global Clinical Trials Review, H1, 2014
出版日: 2014年06月30日 ページ情報: 英文 50 Pages
概要

当レポートでは、世界の主要地域おける四肢麻痺治療薬の治験数や被験者数、段階別の動向、主要企業や機関、治験のプロファイルなどをまとめています。

イントロダクション

  • 四肢麻痺
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数

G7諸国での治験件数:中枢神経系疾患の治験件数に対する四肢麻痺の治験件数比率

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系疾患の治験件数に対する四肢麻痺の治験件数比率

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数 四肢麻痺

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望な薬剤

  • 代表的な研究機関・病院の治験の概要
    • U.S. Department of Veterans Affairs
    • Assistance Publique - Hopitaux de Paris
    • University of British Columbia
    • Seattle Children's Hospital, Research and Foundation
    • University of Alberta
    • VU University Medical Center
    • Rouen University Hospital
    • The Sheba Medical Center
    • University of Oslo
    • Ullevaal University Hospital

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2232CTIDB

GlobalData's clinical trial report, "Quadriplegia / Tetraplegia Global Clinical Trials Review, H1, 2014" provides data on the Quadriplegia / Tetraplegia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Quadriplegia / Tetraplegia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Quadriplegia / Tetraplegia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Quadriplegia / Tetraplegia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Quadriplegia / Tetraplegia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Quadriplegia / Tetraplegia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Quadriplegia / Tetraplegia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Drugs
    • Clinical Trial Overview of Top Institutes / Government
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • University of British Columbia
      • Clinical Trial Overview of University of British Columbia
      • Seattle Children's Hospital, Research and Foundation
      • Clinical Trial Overview of Seattle Children's Hospital, Research and Foundation
      • University of Alberta
      • Clinical Trial Overview of University of Alberta
      • VU University Medical Center
      • Clinical Trial Overview of VU University Medical Center
      • Rouen University Hospital
      • Clinical Trial Overview of Rouen University Hospital
      • The Sheba Medical Center
      • Clinical Trial Overview of The Sheba Medical Center
      • University of Oslo
      • Clinical Trial Overview of University of Oslo
      • Ullevaal University Hospital
      • Clinical Trial Overview of Ullevaal University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Quadriplegia / Tetraplegia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Quadriplegia / Tetraplegia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Quadriplegia / Tetraplegia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Quadriplegia / Tetraplegia to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Quadriplegia / Tetraplegia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, Research and Foundation, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oslo, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ullevaal University Hospital, 2014*

List of Figures

  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Quadriplegia / Tetraplegia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Quadriplegia / Tetraplegia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Quadriplegia / Tetraplegia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Quadriplegia / Tetraplegia to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Quadriplegia / Tetraplegia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Quadriplegia / Tetraplegia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Quadriplegia / Tetraplegia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top